PDF(414 KB)
PDF(414 KB)
PDF(414 KB)
Reducing liver cancer recurrence rate WU Meng-chao. Eastern Hepatobiliary Surgery Hospital,the Second Miliarty Medical University, Shanghai 200438, China
Abstract Hepatectomy is one of the main curative treatment for primary hepatocellular carcinoma (HCC), but postoperative recurrence greatly hinders its long-term outcomes. The factors influencing recurrence after hepatectomy of HCC include patients and their existing tumors, surgical procedures and intervening measures after operation and so on. On one hand, it is useful for decreasing the overall recurrence rate after hepatectomy of HCC to diagnose and operate as early as possible all over the mainland, and to improve the overall surgical levels of hepatectomy. On the other hand, developing new drugs or intervention measures are really to be expected to prevent recurrence of HCC after hepatectomy. Significant progress would be finally made in the field through translational research models and interdisciplinary collaboration.
liver cancer hepatectomy / postoperative recurrence / translational medicine / multidisciplinary collaboration / TACE / radio therapy / molecular targeted therapy
/
| 〈 |
|
〉 |